| Recruiting | Long-term Follow-up of Participants Treated With Galapagos Chimeric Antigen Receptor (CAR) T-cell Therapies Hematological Malignancies | Phase 3 | 2024-09-09 |
| Completed | Relative Bioavailability and Effect of Food Study With an Oral Mini-tablet Formulation of Filgotinib in Health Bioavailability | Phase 1 | 2023-09-22 |
| Active Not Recruiting | A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Sy Systemic Lupus Erythematosus | Phase 2 | 2023-06-28 |
| Active Not Recruiting | A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomy Dermatomyositis | Phase 2 | 2023-02-27 |
| Terminated | A Study Evaluating the Effect of Filgotinib Dose De-escalation in Participants With Ulcerative Colitis (UC) in Ulcerative Colitis | Phase 3 | 2022-07-26 |
| Completed | Evaluation of Mass Balance and Absolute Bioavailability of GLPG3667 Healthy | Phase 1 | 2022-04-19 |
| Active Not Recruiting | A Study Evaluating the Safety and Efficacy of GLPG5101 (19CP02) in Participants With Non-Hodgkin Lymphoma Relapsed/Refractory B-cell Non-Hodgkin Lymphoma, Lymphomas Non-Hodgkin&Amp;Amp;#39;s B-Cell | Phase 1 / Phase 2 | 2022-03-09 |
| Completed | Drug-drug Interaction Study with GLPG3667 and Itraconazole in Healthy Subjects Healthy | Phase 1 | 2022-02-28 |
| Completed | Drug-drug Interaction and Food-effect Study With GLPG4716 and Midazolam in Healthy Subjects Healthy | Phase 1 | 2021-09-08 |
| Completed | A Study to Evaluate How Well Single and Multiple Doses of GLPG3667 Are Tolerated in Healthy, Adult Subjects Healthy | Phase 1 | 2021-07-20 |
| Completed | Drug-drug Interaction Study with GLPG4716 and Nintedanib and Pirfenidone in Healthy Subjects Healthy | Phase 1 | 2021-07-19 |
| Completed | Evaluation of Mass Balance and Absolute Bioavailability of GLPG3970 Healthy | Phase 1 | 2021-06-07 |
| Completed | A Study to Evaluate How Well Single and Multiple Doses of GLPG3121-modified Release Formulation Are Tolerated Healthy | Phase 1 | 2021-04-27 |
| Terminated | A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 12 Weeks in Adults With Active Prima Primary Sjögren Syndrome | Phase 2 | 2021-01-28 |
| Completed | Drug-drug Interaction Study With GLPG3667 and Midazolam in Healthy Subjects Healthy | Phase 1 | 2021-01-15 |
| Completed | Evaluation of Mass Balance and Absolute Bioavailability of GLPG1205 Healthy | Phase 1 | 2021-01-13 |
| Completed | Drug-drug Interaction Study with GLPG3970 and Sulfasalazine in Adult, Healthy Subjects Healthy | Phase 1 | 2021-01-11 |
| Completed | A Study to Assess Relative Bioavailability of and Effect of Food on a New Oral Tablet Formulation of GLPG3970 Healthy | Phase 1 | 2021-01-11 |
| Terminated | A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Systemic Lupus Erythematosus | Phase 1 | 2020-12-28 |
| Terminated | A Study to Evaluate the Effects of GLPG2737 in Participants With Autosomal Dominant Polycystic Kidney Disease Autosomal Dominant Polycystic Kidney Disease | Phase 2 | 2020-11-10 |
| Completed | A Study to Evaluate How Well Single and Multiple Doses of GLPG4399 Are Tolerated in Healthy, Adult Subjects Healthy | Phase 1 | 2020-11-06 |
| Completed | A Study Evaluating the Effects of GLPG3667 Given as an Oral Treatment for 4 Weeks in Adults With Moderate to S Plaque Psoriasis | Phase 1 | 2020-10-19 |
| Completed | A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Moderately to Rheumatoid Arthritis | Phase 2 | 2020-10-12 |
| Completed | A Study Evaluating the Effects of GLPG3970 Given as an Oral Treatment for 6 Weeks in Adults With Ulcerative Co Ulcerative Colitis | Phase 2 | 2020-10-05 |
| Terminated | A Study in Healthy Male Volunteers Investigating the Safety, Absorption and Elimination of Single Doses of GLP Healthy | Phase 1 | 2020-09-16 |
| Completed | A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of GLPG1205 in Healthy Japanese and Caucasi Healthy | Phase 1 | 2020-08-18 |
| Completed | A Study in Healthy Volunteers to Compare Different Tablet Formulations of the Test Medicine, GLPG1972, Against Healthy | Phase 1 | 2019-10-09 |
| Completed | A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3667 Healthy | Phase 1 | 2019-09-18 |
| Completed | A Study in Healthy Male Volunteers to Test How the Test Medicine GLPG1972 is Taken up by the Body When Given b Healthy | Phase 1 | 2019-09-13 |
| Completed | A Study to Evaluate the Effects of Single and Multiple Oral Doses of GLPG3970 Healthy, Psoriasis | Phase 1 | 2019-09-10 |
| Terminated | A Clinical Study to Test Long Term Safety of GLPG1690 for Patients With Systemic Sclerosis Systemic Sclerosis | Phase 2 | 2019-07-18 |
| Completed | Study to Evaluate the Effect of Filgotinib on Semen Parameters in Adult Males With Active Rheumatoid Arthritis Rheumatoid Arthritis, Psoriatic Arthritis, Ankylosing Spondylitis | Phase 2 | 2019-05-28 |
| Completed | A Study to Evaluate the Effects of a Single and Multiple Oral Doses of GLPG3121 in Adult, Healthy, Male Subjec Healthy | Phase 1 | 2019-03-29 |
| Terminated | A Study to Evaluate the Safety and Tolerability of MOR106 Administered Concomitantly With Topical Corticostero Atopic Dermatitis | Phase 2 | 2019-03-25 |
| Completed | A Study Investigating the Safety, Absorption and Elimination of GLPG3312, a New Drug in the Treatment of Infla Healthy | Phase 1 | 2019-01-15 |
| Completed | A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Systemic Sclerosis Systemic Sclerosis | Phase 2 | 2019-01-14 |
| Terminated | A Clinical Study to Test How Effective and Safe GLPG1690 is for Subjects With Idiopathic Pulmonary Fibrosis (I Idiopathic Pulmonary Fibrosis | Phase 3 | 2018-11-28 |
| Completed | A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Give Healthy | Phase 1 | 2018-11-09 |
| Terminated | A Clinical Study to Test How Effective and Safe GLPG1690 is for Participants With Idiopathic Pulmonary Fibrosi Idiopathic Pulmonary Fibrosis | Phase 3 | 2018-11-05 |
| Completed | A Clinical Study to Test How Effective and Safe GLPG1205 is for Participants With Idiopathic Pulmonary Fibrosi Idiopathic Pulmonary Fibrosis | Phase 2 | 2018-09-27 |
| Completed | A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis Osteoarthritis | Phase 2 | 2018-08-14 |
| Terminated | A Study to Test Safety, Tolerability, and the Way the Body Absorbs, Distributes, and Gets Rid of a Study Drug Healthy, Atopic Dermatitis | Phase 1 | 2018-08-13 |
| Completed | A Study Looking at the Safety, Tolerability and Efficacy of the Combination of the Study Drugs GLPG2451 and GL Cystic Fibrosis | Phase 1 | 2018-05-31 |
| Terminated | A Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics (PK)/Pharmacodynamics (PD) of MOR106 in Atopic Dermatitis | Phase 2 | 2018-04-26 |
| Completed | A Study in Healthy Male Volunteers to Look at How the Test Medicine GLPG1690 is Taken up by the Body When Dose Healthy | Phase 1 | 2018-03-16 |
| Completed | Pharmacokinetics of GLPG3067 in Male Subjects With Cystic Fibrosis. Cystic Fibrosis | Phase 1 | 2018-02-12 |
| Completed | GLPG2737 on Top of Orkambi in Subjects With Cystic Fibrosis Cystic Fibrosis | Phase 2 | 2017-11-29 |
| Terminated | An Open-label, Long-term Extension Study With Filgotinib in Active Psoriatic Arthritis. Psoriatic Arthritis | Phase 2 | 2017-07-26 |
| Terminated | Study to Evaluate the Testicular Safety of Filgotinib in Adult Males With Moderately to Severely Active Inflam Inflammatory Bowel Disease | Phase 2 | 2017-07-11 |
| Completed | Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis Cystic Fibrosis | Phase 1 | 2017-06-28 |
| Completed | A Study With GLPG1972 in Osteoarthritis Subjects Osteoarthritis | Phase 1 | 2017-05-15 |
| Completed | Study to Assess Bioavailability of GLPG1690 Given as Oral Capsule or Tablet Healthy | Phase 1 | 2017-04-18 |
| Completed | Study to Compare Bioavailability of GLPG1972 Given as 2 Different Tablet Formulations Versus an Oral Solution Healthy | Phase 1 | 2017-04-14 |
| Completed | A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG3067 in Healthy Subjects. Healthy | Phase 1 | 2017-03-28 |
| Completed | A Study to Evaluate Multiple Doses of GLPG2222 in Adult Subjects With Cystic Fibrosis Cystic Fibrosis | Phase 2 | 2017-03-18 |
| Terminated | Filgotinib in Long-Term Extension Study of Adults With Crohn's Disease Crohn's Disease | Phase 3 | 2017-03-17 |
| Completed | A Study to Assess Efficacy and Safety of Filgotinib in Active Psoriatic Arthritis Psoriatic Arthritis | Phase 2 | 2017-03-09 |
| Completed | A Study to Assess Efficacy and Safety of Filgotinib in Ankylosing Spondylitis Ankylosing Spondylitis | Phase 2 | 2017-03-07 |
| Completed | A Study to Evaluate GLPG2222 in Ivacaftor-treated Subjects With Cystic Fibrosis Cystic Fibrosis | Phase 2 | 2017-01-01 |
| Completed | A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2737 in Healthy Subjects Healthy | Phase 1 | 2016-11-25 |
| Completed | A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Male Subjects Healthy | Phase 1 | 2016-11-14 |
| Completed | Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Crohn's Disease | Phase 3 | 2016-10-31 |
| Completed | This is a Study to Evaluate the Effect of Aging of Multiple Doses of GLPG1205 in Healthy Subjects Healthy, Elderly | Phase 1 | 2016-10-18 |
| Completed | Bioavailability Study With GLPG1972 Osteoarthritis | Phase 1 | 2016-07-01 |
| Completed | A Study to Assess Safety, Tolerability and Pharmacokinetics of GLPG2451 in Healthy Female Subjects Healthy | Phase 1 | 2016-04-14 |
| Completed | First in Human of Single and Multiple Doses of MOR106 Healthy, Dermatitis, Atopic | Phase 1 | 2016-04-01 |
| Completed | Study to Assess Safety, Tolerability, Pharmacokinetic and Pharmacodynamic Properties of GLPG1690 in Subjects W Idiopathic Pulmonary Fibrosis | Phase 2 | 2016-03-01 |
| Completed | Study of GLPG1837 in Subjects With Cystic Fibrosis (G551D Mutation) Cystic Fibrosis | Phase 2 | 2016-02-01 |
| Completed | Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation) Cystic Fibrosis | Phase 2 | 2016-01-01 |
| Completed | First-in-Human Single and Multiple Dose of GLPG2222 Healthy | Phase 1 | 2016-01-01 |
| Completed | First-in-Human Single and Multiple Dose of GLPG1972 Healthy | Phase 1 | 2015-11-01 |
| Completed | A Drug-drug Interaction Study Between GLPG1205 and a Cocktail of CYP450 Substrates in Healthy Male Subjects Healthy | Phase 1 | 2015-10-01 |
| Completed | Oral Bioavailability of Solid Formulation of GLPG1837 With and Without Food Healthy | Phase 1 | 2015-09-01 |
| Completed | A Phase I, Open Interaction Study Between GLPG1837 and Midazolam in Healthy Male Subjects Healthy | Phase 1 | 2015-09-01 |
| Completed | Efficacy and Safety of GLPG1205 in Subjects With Active Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2014-12-01 |
| Completed | First-in-Human Single and Multiple Dose of GLPG1837 Healthy | Phase 1 | 2014-12-01 |
| Completed | First-in-Human Single and Multiple Dose of GLPG1690 Healthy | Phase 1 | 2014-06-01 |
| Completed | Multiple Ascending Dose Study of GLPG0634 in Japanese and Caucasian Healthy Subjects Healthy | Phase 1 | 2014-06-01 |
| Completed | Oral Bioavailability of Solid Formulation of GLPG1205 With and Without Food Healthy | Phase 1 | 2014-05-01 |
| Completed | Study to Evaluate GLPG0634 in Subjects With Renal Impairment Compared to Healthy Subjects Renal Impairment | Phase 1 | 2014-03-01 |
| Completed | Long-term Follow-up Study of GLPG0634 in Active Rheumatoid Arthritis Participants Rheumatoid Arthritis | Phase 2 | 2014-02-25 |
| Completed | Efficacy and Safety of GLPG0634 in Subjects With Active Crohn's Disease Crohn's Disease | Phase 2 | 2014-02-01 |
| Completed | Dose-finding Study of GLPG0634 as Monotherapy in Active Rheumatoid Arthritis (RA) Participants (DARWIN2) Rheumatoid Arthritis | Phase 2 | 2013-10-08 |
| Completed | Dose-finding Study of GLPG0634 as add-on to Methotrexate in Active Rheumatoid Arthritis Participants (DARWIN1) Rheumatoid Arthritis | Phase 2 | 2013-07-17 |
| Completed | Oral Bioavailability of Two Solid Formulations of GLPG0634 Healthy | Phase 1 | 2013-07-01 |
| Completed | First-in-Human Single and Multiple Dose of GLPG1205 Healthy | Phase 1 | 2013-06-01 |
| Completed | Safety, Efficacy, Pharmacokinetic and Pharmacodynamic Study of GLPG0974 in Subjects With Ulcerative Colitis Ulcerative Colitis | Phase 2 | 2013-04-01 |
| Completed | Investigation of the Pharmacokinetics and Metabolism of GLPG0634 in Healthy Male Subjects Healthy | Phase 1 | 2013-03-01 |
| Completed | A Phase I, Open Interaction Study Between GLPG0634 and Midazolam in Healthy Subjects Healthy | Phase 1 | 2013-02-01 |
| Completed | Multiple Ascending Dose Study of GLPG0974 in Healthy Subjects Healthy | Phase 1 | 2012-10-01 |
| Completed | Single and Multiple Dose Pharmacokinetics of GLPG0634 in Elderly Healthy Subjects Healthy | Phase 1 | 2012-07-01 |
| Completed | Dose-ranging Study With GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients Rheumatoid Arthritis | Phase 2 | 2012-05-01 |
| Completed | GLPG0492 Pharmacodynamics Healthy | Phase 1 | 2012-01-01 |
| Completed | Bioavailability Study of Prodrug of GLPG0187 in Healthy Volunteers Healthy | Phase 1 | 2012-01-01 |
| Completed | First-in-Human Exploratory Single Ascending Dose of GLPG0974 Healthy | Phase 1 | 2011-12-01 |
| Completed | Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Oral Doses of GLPG0634 in Healthy Subj Healthy | Phase 1 | 2011-08-01 |
| Completed | Multiple Ascending Dose Study of GLPG0492 in Healthy Subjects Healthy | Phase 1 | 2011-07-01 |
| Completed | Safety and Preliminary Efficacy of GLPG0634 in Methotrexate-refractory Active Rheumatoid Arthritis Patients Rheumatoid Arthritis | Phase 2 | 2011-06-01 |
| Completed | GLPG0778: Multiple Ascending Oral Doses, Pharmacokinetic, Safety, and Pharmacodynamic Study Healthy | Phase 1 | 2011-04-01 |
| Completed | GLPG0187: Safety, Tolerability and Pharmacokinetics in Patients With Solid Tumors Solid Tumors | Phase 1 | 2011-03-01 |
| Completed | Oral Bioavailability of GLPG0555 in Different Solid Formulations Healthy | Phase 1 | 2011-01-01 |
| Completed | First-in-Human Single Ascending and Multiple Dose of GLPG0778 Healthy | Phase 1 | 2010-12-01 |
| Completed | Oral Bioavailability of Two Solid Formulations of GLPG0259. Healthy | Phase 1 | 2010-11-01 |
| Completed | GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis Rheumatoid Arthritis | Phase 2 | 2010-10-01 |
| Completed | Pharmacokinetics/Pharmacodynamics (PK/PD) of Multiple Oral Doses of GLPG0555 in Healthy Subjects Healthy | Phase 1 | 2010-09-01 |
| Completed | First-in-Human Single Ascending and Multiple Dose of GLPG0634 Healthy | Phase 1 | 2010-08-01 |
| Completed | First-in-Human Single Ascending Dose of GLPG0492 Healthy | Phase 1 | 2010-05-01 |
| Completed | First-in-Human Single Ascending and Multiple Dose of GLPG0555 Healthy | Phase 1 | 2009-12-01 |
| Terminated | Nanocort in Acute Exacerbation of Relapsing-Remitting Multiple Sclerosis (MS) Acute Exacerbation of Remitting Relapsing Multiple Sclerosis, Clinically Isolated Syndrome | Phase 2 | 2009-12-01 |
| Completed | GLPG0259 Solid Formulation Bioavailability and Food Effect Healthy | Phase 1 | 2009-11-01 |
| Completed | GLPG0259 Multiple Ascending Dose and Methotrexate Drug-drug Interaction (DDI) in Healthy Subjects Healthy | Phase 1 | 2009-09-01 |
| Completed | First-in-Human Single Ascending Subcutaneous (s.c.) Dose and Single Oral Dose of GLPG0187 Healthy | Phase 1 | 2009-06-01 |
| Completed | First-in-Human Single Ascending and Multiple Dose of GLPG0259 Healthy | Phase 1 | 2009-03-01 |